B. Schwartz

How Often Should a Port-A-Cath be Flushed?

Yuo‐Chen Kuo, B. Schwartz, Jeferson Batista Santiago et al. · Cancer Investigation · 2005 · 65 citations

Medicine, Internal Medicine, Drug Utilization Review +5

Prophylaxis in factor IX deficiency product and patient variation

C. Thomas Kisker, A. Eisberg, B. Schwartz · Haemophilia · 2003 · 49 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Acute promyelocytic leukaemia and acquired α‐2‐plasmin inhibitor deficiency: a retrospective look at the use of epsilon‐aminocaproic acid (Amicar) in 30 patients

Trudy M. Wassenaar, J Black, Brad S. Kahl et al. · Hematological Oncology · 2008 · 26 citations

Medicine, Hematology, Pharmacology +12

POS-109 INTERIM RESULTS OF PHASE 1 AND 2 TRIALS TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS, AND CLINICAL ACTIVITY OF BION-1301 IN PATIENTS WITH IgA NEPHROPATHY

Jonathan Barratt, Billy Hour, Laura Kooienga et al. · Kidney International Reports · 2022 · 15 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +8

Identification of the APUD endocrine cells of rat fundic mucosa by means of combined amine fluorescence and electron microscopy.

Walter Rubin, B. Schwartz · Journal of Histochemistry & Cytochemistry · 1984 · 12 citations

Medicine, Endocrinology, Biochemical Pharmacology +6